Cytosorbents Corp (CTSO) stock
CTSONasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
$4.87−0.50 (-9.31%)
Close on Nov 13, 2026Market cap $306.04MP/E –Yield –
Cytosorbents price to sales ratio
The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.
Cytosorbents's price to sales ratio was 9.0× on Nov 11, 2026, against 27.5× a year earlier. Over the last 5 years it ranged from 6.6× to 88.8×, with a median of 32.4×.
Price to Sales Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 9.0× | −12.7 |
| 2025 | Dec 31, 2025 | 21.7× | −6.5 |
| 2024 | Dec 31, 2024 | 28.2× | +2.0 |
| 2023 | Dec 29, 2023 | 26.3× | −11.2 |
| 2022 | Dec 30, 2022 | 37.5× | −44.7 |
| 2021 | Dec 31, 2021 | 82.2× | −106.5 |
| 2020 | Dec 31, 2020 | 188.7× | +82.9 |
| 2019 | Dec 31, 2019 | 105.8× | −136.8 |
| 2018 | Dec 31, 2018 | 242.6× | −29.9 |
| 2017 | Dec 29, 2017 | 272.5× | −65.8 |
| 2016 | Dec 30, 2016 | 338.3× | +22.5 |
| 2014 | Nov 28, 2014 | 315.9× | +30.5 |
| 2013 | Dec 31, 2013 | 285.3× | – |
See a number that looks wrong?